Type your tag names separated by a space and hit enter

Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58)

Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Dapagliflozin in High-risk T2DM Reduces Hospitalization for HF, but Does Not Reduce Death, MI, or Stroke (DECLARE-TIMI 58)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314712/all/Dapagliflozin_in_high_risk_T2DM_reduces_hospitalization_for_HF__but_does_not_reduce_death__MI__or_stroke__DECLARE_TIMI_58_.
Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58). In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314712/all/Dapagliflozin_in_high_risk_T2DM_reduces_hospitalization_for_HF__but_does_not_reduce_death__MI__or_stroke__DECLARE_TIMI_58_. Accessed March 21, 2019.
Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58). (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314712/all/Dapagliflozin_in_high_risk_T2DM_reduces_hospitalization_for_HF__but_does_not_reduce_death__MI__or_stroke__DECLARE_TIMI_58_
Dapagliflozin in High-risk T2DM Reduces Hospitalization for HF, but Does Not Reduce Death, MI, or Stroke (DECLARE-TIMI 58) [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314712/all/Dapagliflozin_in_high_risk_T2DM_reduces_hospitalization_for_HF__but_does_not_reduce_death__MI__or_stroke__DECLARE_TIMI_58_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Dapagliflozin in high-risk T2DM reduces hospitalization for HF, but does not reduce death, MI, or stroke (DECLARE-TIMI 58) ID - 1314712 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314712/all/Dapagliflozin_in_high_risk_T2DM_reduces_hospitalization_for_HF__but_does_not_reduce_death__MI__or_stroke__DECLARE_TIMI_58_ PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -